FNY Managed Accounts’s Altimmune ALT Stock Holding History

FNY Managed Accounts’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-33	Closed	-$1K	–	599
2017 Q4	$1K	Buy	+33	New	+$2.11K	﹤0.01%	552

Other funds holding ALT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

LIM

Leavell Investment Management Mobile, Alabama $2.74B AUM 26.51% 1-Year Est. Return

FNY Managed Accounts's ALT Position: Q1 2018 in Review

FNY Managed Accounts sold out of Altimmune (ALT) in Q1 2018, closing a stake of 33 shares — an estimated $1K sold.

FNY Managed Accounts first reported a position in ALT in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 26 funds tracked by Wall St. Rank hold ALT as of Q1 2018.

FNY Managed Accounts reported no remaining Altimmune position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 33 Altimmune shares in Q1 2018, an estimated $1K.
FNY Managed Accounts first reported a position in Altimmune in Q4 2017 and held it in 1 quarter.
FNY Managed Accounts's Altimmune position peaked at $1K in Q4 2017.
26 funds tracked by Wall St. Rank held Altimmune as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.